Vyxeos liposomal (previously Vyxeos)
Active substance: daunorubicin hydrochloride, cytarabine
daunorubicin hydrochloride, cytarabine
Centralised EU authorisationActive
Marketing holder: Jazz Pharmaceuticals Ireland Limited
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| RU 9 |
|
| US 6 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-3f0d-7a69-9593-c9452e4a2667,01a120c3-f906-7c25-82e2-c1c215e038df,01a120c3-f975-720e-90df-6066822cfab0,01a120c5-03d1-7161-b827-4ae45c688ae5,01a120c5-5dc1-716f-814b-55bf32e707eb;count=8 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-14bf-7906-a4ab-04064ed9eaf1,01a1208f-a965-740f-887d-c8bc9dc06ff6,01a12098-5c6b-7451-a705-a3cc98db53d9,01a12098-63ff-7a8b-8562-8595bd5f0902,01a1209b-e305-77d2-895b-50cce76bc689;count=5 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- EMEA/H/C/004282
- Registration status
- Active
- ATC code
- L01XY01
- product · EMA · EMEA/H/C/004282 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/004282 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/004282 · Verified 2026-10-09
- ingredients.1 · EMA · EMEA/H/C/004282 · Verified 2026-10-09